Multi‐Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations
ABSTRACT Alzheimer's disease (AD) is a complex and multifactorial neurodegenerative disorder, recognized as the most prevalent form of dementia. It is characterized by multiple pathological processes, including amyloid‐beta accumulation, neurofibrillary tangles, and neuroinflammation. The thera...
Saved in:
| Main Authors: | Md Saad Hossain, Md Hamed Hussain |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Pharmacology Research & Perspectives |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prp2.70131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanocarrier-based targeted drug delivery for Alzheimer’s disease: addressing neuroinflammation and enhancing clinical translation
by: Kang Wang, et al.
Published: (2025-05-01) -
Carbon nanotubes in brain targeted drug delivery: A comprehensive review
by: Sourav Das, et al.
Published: (2025-05-01) -
The role of gut microbiota dysbiosis in drug-induced brain injury: mechanisms and therapeutic implications
by: Jinghui Zhai, et al.
Published: (2025-08-01) -
Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
by: Shaoqing Du, et al.
Published: (2025-03-01) -
Resistance mutations and the blood–brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancer
by: Jamie Rijmers, et al.
Published: (2025-08-01)